A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
ALX Oncology Inc.
Seagen Inc.
Seagen Inc.
Novartis
Kivu Bioscience Inc.
Exelixis
EvolveImmune United, Inc
Plexium, Inc.
Pfizer
Coherus Oncology, Inc.
IDEAYA Biosciences
West China Hospital
IDEAYA Biosciences
Radiopharm Theranostics, Ltd
Rondo Therapeutics
Novartis
MacroGenics
Prelude Therapeutics
UMC Utrecht
AbbVie
Innate Pharma
Shanghai Zhongshan Hospital
Jacobio Pharmaceuticals Co., Ltd.
Seagen Inc.
Shanghai Junshi Bioscience Co., Ltd.
NeoTX Therapeutics Ltd.
Incyte Corporation
Beijing Immupeutics Medicine Technology Limited
Novartis
Sichuan University
Hoffmann-La Roche
Sun Yat-sen University
Incyte Corporation
National Cancer Institute (NCI)
Novartis
National Cancer Center, Japan
Allist Pharmaceuticals, Inc.
Exelixis
Molecular Templates, Inc.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Hebei Medical University Fourth Hospital
Symphogen A/S
Eisai Inc.
West China Hospital
Atreca, Inc.
Peking University Cancer Hospital & Institute
Ruijin Hospital
Affiliated Cancer Hospital of Shantou University Medical College
Fujian Cancer Hospital
Gossamer Bio Inc.